[HTML][HTML] COVID-19: molecular and cellular response
In late December 2019, a vtiral pneumonia with an unknown agent was reported in Wuhan,
China. A novel coronavirus was identified as the causative agent. Because of the human-to …
China. A novel coronavirus was identified as the causative agent. Because of the human-to …
[HTML][HTML] Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19)
In December 2019, an acute respiratory disease caused by novel species of coronavirus
(SARS-CoV-2), emerged in China and has spread throughout the world. On 11 th March …
(SARS-CoV-2), emerged in China and has spread throughout the world. On 11 th March …
[HTML][HTML] Molecular immune pathogenesis and diagnosis of COVID-19
X Li, M Geng, Y Peng, L Meng, S Lu - Journal of pharmaceutical analysis, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of …
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of …
[HTML][HTML] Recent understandings toward coronavirus disease 2019 (COVID-19): from bench to bedside
In late December 2019, an unprecedented outbreak of coronavirus disease 2019 (COVID-
19) caused by SARS coronavirus 2 (SARS-CoV-2)(previously named 2019-nCoV) in Wuhan …
19) caused by SARS coronavirus 2 (SARS-CoV-2)(previously named 2019-nCoV) in Wuhan …
Coronavirus diseases 2019: current biological situation and potential therapeutic perspective
Abstract Coronavirus Disease 2019 (COVID-19) caused by a Severe Acute Respiratory
Syndrome Coronavirus-2 (SARS-CoV-2) was first reported in Wuhan, China at the end of …
Syndrome Coronavirus-2 (SARS-CoV-2) was first reported in Wuhan, China at the end of …
Current understanding of novel coronavirus: molecular pathogenesis, diagnosis, and treatment approaches
An outbreak of “Pneumonia of Unknown Etiology” occurred in Wuhan, China, in late
December 2019. Later, the agent factor was identified and coined as severe acute …
December 2019. Later, the agent factor was identified and coined as severe acute …
[HTML][HTML] Advances in pathogenesis, progression, potential targets and targeted therapeutic strategies in SARS-CoV-2-Induced COVID-19
H Zhou, WJ Ni, W Huang, Z Wang, M Cai… - Frontiers in …, 2022 - frontiersin.org
As the new year of 2020 approaches, an acute respiratory disease quietly caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus …
Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics
The emergence of a new coronavirus, in around late December 2019 which had first been
reported in Wuhan, China has now developed into a massive threat to global public health …
reported in Wuhan, China has now developed into a massive threat to global public health …
Novel SARS-CoV-2/COVID-19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis
In this review, we focused on the origins of the novel coronavirus (SARS-CoV-2), origin,
pathogenesis, immune responses, genes and genetic variations, phylogenetic analyses …
pathogenesis, immune responses, genes and genetic variations, phylogenetic analyses …
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the …
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the …